UBS Group’s Neo-Concept International Group Holdings NCI Stock Holding History

UBS Group’s Portfolio NCI Stock Details NCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16	Sell	1 -4	-80%	-$128	﹤0.01%	10308
2025 Q4	$44	Buy	+5	New	+$57	﹤0.01%	10287
2025 Q3	–	Sell	-28	Closed	-$524	–	11083
2025 Q2	$524	Sell	28 -193	-87%	-$3.05K	﹤0.01%	9805
2025 Q1	$4.24K	Buy	221 +210	+1,909%	+$4.43K	﹤0.01%	9128
2024 Q4	$303	Buy	+11	New	+$283	﹤0.01%	9528
2024 Q3	–	Sell	-1,634	Closed	-$41.2K	–	10194
2024 Q2	$41.2K	Buy	+1,634	New	+$75.7K	﹤0.01%	6840

Other funds holding NCI

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return

UBS Group's NCI Position: Q1 2026 in Review

UBS Group reduced its Neo-Concept International Group Holdings (NCI) stake by 80% in Q1 2026, selling an estimated $128 and leaving 1 share worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #10308.

UBS Group first reported a position in NCI in Q2 2024 and has held it in 6 quarters since. The position peaked at $41.2K in Q2 2024. 4 funds tracked by Wall St. Rank hold NCI as of Q1 2026.

UBS Group held 1 share of Neo-Concept International Group Holdings worth $16 as of Q1 2026.
UBS Group sold 4 Neo-Concept International Group Holdings shares in Q1 2026, an estimated $128.
Neo-Concept International Group Holdings made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10308 holding.
UBS Group first reported a position in Neo-Concept International Group Holdings in Q2 2024 and has held it in 6 quarters since.
UBS Group's Neo-Concept International Group Holdings position peaked at $41.2K in Q2 2024.
4 funds tracked by Wall St. Rank held Neo-Concept International Group Holdings as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.